1. Home
  2. MGN vs PDSB Comparison

MGN vs PDSB Comparison

Compare MGN & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MGN

Megan Holdings Limited Ordinary Shares

N/A

Current Price

$1.80

Market Cap

43.0M

Sector

N/A

ML Signal

N/A

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.88

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGN
PDSB
Founded
2020
2005
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.0M
49.5M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
MGN
PDSB
Price
$1.80
$0.88
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
33.0K
592.3K
Earning Date
01-29-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$13,484,571.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$0.70
52 Week High
$8.63
$2.20

Technical Indicators

Market Signals
Indicator
MGN
PDSB
Relative Strength Index (RSI) N/A 49.68
Support Level N/A $0.86
Resistance Level N/A $0.93
Average True Range (ATR) 0.00 0.07
MACD 0.00 -0.00
Stochastic Oscillator 0.00 11.26

Price Performance

Historical Comparison
MGN
PDSB

About MGN Megan Holdings Limited Ordinary Shares

Megan Holdings Ltd is principally engaged in the development, construction and maintenance of aquaculture farms and related works. Its operations are based in Malaysia. The company's operating segments include: Aquaculture and agriculture; Industrial solutions; and Investment in marketable securities. It derives maximum revenue from Aquaculture and agriculture, which involves development, construction, and maintenance of aquaculture and agriculture farms and related works.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: